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Introduction  
Food transmitted diseases are a big issues for public health worldwide and food-borne outbreaks 
from several sources are continuously reported caused by different infectious agents, as reviewed 
in Vitale and Schillaci (2016). Bacterial infection and contamination can be more complex and 
difficult to treat when pathogenic bacteria are organized in structural community named biofilms. 
Biofilm bacteria are more resistant to drugs and other treatments and their important role for 
infectious diseases in animals, has been explored in the last decades (Clutterbuck et al. 2007).  
However biofilms are also a big concern for food safety for the contamination of surfaces and 
equipment in food processing industries (Srey, et al. 2013). Staphylococcus aureus is a relevant 
pathogen for mastitis in dairy farms and S. aureus biofilms are considered important in recurrent 
mastitis (Melchior et al., 2006). 
The intercellular adhesion (ica) locus (Cramton et al., 1999), bap gene (Cucarella et al., 2004) and 
sas C gene (Schroeder et al., 2009) are involved in the organization of staphylococcal biofilm. The 
infected animals can contaminate milk, dairy products, meat with a consequent major risk for food-
borne transmission to humans. The discovery of new drugs against sessile bacteria is considered a 
good strategy to control the infection and the diffusion of food transmitted pathogens (Simo˜es et 
al., 2010).With the aim of discovering new antibacterial drugs active against planktonic bacteria 
and /or biofilms, we have focused on the pyrrolomycins (Schillaci et al., 2010).  
The evaluation of biofilm formation in food isolates of S. aureus, in relation to the presence of ica, 
bap and sas C was performed together with the assays  for  the antimicrobial activity of a new 
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chemically synthesized nitro-derivative pyrrolomycin, the (3,5-dichloro-2-hydroxyphenyl)(4-nitro-
1H-pyrrol-2-yl)methanone (IV).  
Materials and Methods 
Synthesis of compound IV 
Synthesis of (3,5-dichloro-2-hydroxyphenyl)(4-nitro-1H-pyrrol-2-yl)methanone (IV). The compound 
was synthesized and characterised as already described (Raimondi et al., 2006). 
Figure 1: Chemical structure of (3,5-dichloro-2-hydroxyphenyl)(4-nitro-1H-pyrrol-2-yl)methanone IV 
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Bacterial strains 
Two reference strains: S. aureus ATCC 25923, S. epidermidis RP62A, and a group of 20 food strains 
of S. aureus were analysed. The isolates were subjected to Gram staining and biochemical analysis such 
as catalase and Voges-Proskauer (VP) test (BioMérieux), oxidase test (Oxoid), glucose and mannitol 
acidification in red phenol broth (Difco). Further identification was performed using the API Staph 
system (BioMérieux, Marcy l'Etoile, 20500, France). 
MICs determination. 
Minimum inhibitory concentrations (MICs) against planktonic strains were determined as previously 
described in Schillaci et al. (2010).  
Molecular characterization  
DNA was extracted using QIAmp DNA mini kit spin columns according to the manufacturer’s 
instructions (Quiagen SpA, Milan, Italy). Staphylococcus spp. isolates were investigated by PCR for the 
presence of the intercellular adhesion (ica) locus, biofilm-associated protein (bap) as described in 
Cucarella et al. (2004) and Sas (Srinivasan et al. 2006). 
Biofilm capability evaluation 
All the staphylococcal strains were tested for their ability to form biofilms by safranin staining method 
( Schillaci et al., 2010). The same method  was also used to evaluate a preventive activity on the three 
strongest strains by directly adding to the diluted suspension, sub-MIC concentrations of pyrrolomycin 
IV.  
Biofilm susceptibility testing, methylthiazotetrazolium (MTT) method were performed as described in  
Schillaci et al. (2010) 
All biofilm assays were performed in triplicate. 
Results 
The results on genes showed that bap was present in 1/20, ica was detected in 16/20 strains and sasC in 
8/20 but biofilm capability was not related to the presence of genes. (Table 1)  
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Table 1: Biofilm capability (Optical Density, O.D.) and genes  
Staphylococcus strains  D.O ica  bap  sas C 
S.epidermidis RP 62A  3.010  + - - 
S.aureus ATCC 25923 1.956  + - + 
S.aureus 708 1.896 + - + 
S.aureus 637 1.668 - - - 
S.aureus 1553 1,337 + - + 
S.aureus 353 1.104 + - - 
S. aureus 357 1.044 + - + 
S. aureus 723 1.016 + - - 
S.aureus 100 0.989 + - - 
S.aureus 722 0.959 + - + 
S.aureus 712 0.932 + - + 
S. aureus 635 0.855 - - - 
S.aureus 714 0.851 + - - 
S.aureus 242  0.786 + - - 
S.aureus 713* 0.737 + + + 
S.aureus 725 0.713 + - - 
S.aureus 191  0.648 + - - 
S.aureus 1559 0.641 - - - 
S.aureus 165 0.585 + - - 
S.aureus 636 0.541 - - - 
S.aureus 711 0.528 + - + 
S.aureus 1704 0.391 + - + 
Biofilm formation strength, was high in the two references strains followed by S. aureus isolate N708 
(ica+, bap- and sas C+); similar OD values were obtained with the S aureus isolate (N 635.) in which all 
three loci are absent. The N 713 strain, presenting all three genetic loci showed a 50% biofilm capability 
compared to N 708. The analysis of antibacterial activity of the compound IV showed that it was 
effective against all planktonic forms of the tested strains with MICs values ranging from 0.4 to 0.2 
µg/mL. The strongest biofilm producers N708, together with the reference strains S.aureus ATCC 
25923, and S. epidermidis RP62A, were used to evaluate the anti-biofilm properties of pyrrolomycin IV 
on 24 hours established biofilms and before biofilm formation. The anti-biofilm activity against 24 hours 
pre-formed biofilm was observed at concentrations of 1.6 or 0.8 µg/mL, which were higher compared 
to the MIC values obtained on planktonic forms (Tab.2).  
Table 2: Anti-microbial activity of pyrrolomycin IV against the stronger biofilm producer strains  
 
MIC (µg/mL)  
(no growth in 
planctonic) 
MIC (µg/mL) 
in preformed biofilm 
 
Strains  1.6 0.8 0.4 0.2 
S. epidermidis RP62A 0·4 92·4 89·.5 33·6 NS 
S. aureus ATCC 25923 0·2 54 41 30·6 NS 
S. aureus 353 0·2 89 66 20 NS 
S.aureus 708 0·4 80·6 62·5 27 NS 
S.aureus 723 0·2 88 79 19 NS 
Values are the average of at least three independent determinations.  
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Variation coefficient was less than 15%. NS = not significant because below the 15% of inhibition.  
The anti-planktonic activity  showed MIC values between 0.2 and 0.4 for all isolates.  
A higher MIC values (0,8-1,6) were necessary to inhibit at least 62% in the preformed biofilm of the 
field isolates. 
 
An ability of the compound to prevent biofilm on two reference staphylococcal strains and S.aureus 
strain N 708, was shown at concentrations of 0.18, 0.09 and 0.045 µg/mL , lower than the MIC values 
established in planktonic forms. Indeed, almost 50% of biofilm was inhibited at concentration of 0.09 
µg/mL (Table 3 ).  
Table 3: Inhibition of biofim formation at sub-MIC concentrations(µg/mL) 
The activity is expressed as percentage of inhibition.  
Strains 0.18  0.09  0.045  
S. epidermidis RP62A 46·4 43.1 34.7 
S. aureus ATCC 25923 56·5 44.5 29·1 
S. aureus 708 55 52 42·5 
An average of 52% and 46% inhibitor percentage was present at sub MIC concentration of 0.18 and 
0.09  µg/mL respectively. These results look very promising for the prevention of Biofilm formation,  
considering the very low level of the active concentration of compound IV.  
Discussion  
The results showed that the capability Staphylococcus spp. strains in biofilm formation is not related to 
the presence or absence of the genetic loci analysed in this study. This might be due to the fact that in 
vitro biofilm organization often depends on several factors such as  the composition of the culture media 
(Ferreira et al. 2012). In contrast to human isolates, the lack of a role for the ica operon on the formation 
of biofilm by S.aureus isolates from bovine mastitis, has already been described (O’Gara 2007). The 
existence of alternative mechanisms to induce biofilm development implies that each S. aureus isolate 
might develop a particular type of biofilm matrix to better suit the environmental conditions (Schroeder 
et al., 2009).  
Bacterial infections in livestock animals represent a big concern for food safety since the pathogenic 
bacteria can contaminate food products and transmit infection and disease to humans. Animal with 
clinical or subclinical mastitis caused by S.aureus can contaminate the milk with strains that often 
harbour several virulent factors like enterotoxins and toxic shock syndrome genes (Srinivasan et al. 
2006). More than 280 episodes of food poisoning episodes due to staphylococcal enterotoxins have been 
reported each year in Europe (EFSA report, 2010). Staphylococcal enterotoxins poisoning cases and the 
circulation of virulent S. aureus strains in milk and food samples have been reported already in Sicily, 
Italy where mastitis problems in cattle and sheep are frequently  reported (Vitale et al 2015, 2018) 
Conclusion 
The new synthetic pyrrolomycin IV showed good antimicrobial property against planktonic form of S. 
aureus and in preventing staphylococcal biofilm. A more efficacious control of bacterial biofilm can 
result in a lower number of antimicrobial treatments, a reduction in the spread of antibiotic resistance 
and a control of pathogenic bacteria in livestock farms. The community and sessile forms of pathogenic 
bacteria are in fact involved in the recurrence of infection in animals but also in persistent contamination 
of food production premises.  
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